Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s ...

Leap Therapeutics ( ($LPTX) ) has shared an update. On October 6, 2025, Leap Therapeutics entered into a Securities Purchase Agreement for a ...

In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials evaluating the safety and efficacy of tulisokibart (MK-7240), an ...

A Cologne-led research team has discovered the antibody 04_A06, which neutralizes the human immunodeficiency virus (HIV) in almost all tested variants in vitro and even overcomes typical resistance ...

Neuromyelitis optica spectrum disorder (NMOSD) is neuroinflammatory disease characterized by optic neuritis and myelitis with presence of anti-aquaporin-4 (AQP4) antibodies. Satralizumab is an anti-IL ...

Dualitas Therapeutics launched today with a $65 million series A financing round and a pipeline of bispecific antibodies for immune and inflammatory diseases. Bispecific antibodies are designed to ...

Abstract: The advent of evanescent field based fiber optic biosensor and advancements in nanotechnology has create an excellent opportunity in label-free detection of biomarkers which plays vital role ...